BriaCell Therapeutics (TSX:BCT) Tax Rate % : 0.00% (As of Jan. 2025)

View and export this data going back to 2006. Start your Free Trial

What is BriaCell Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. BriaCell Therapeutics's Tax Expense for the three months ended in Jan. 2025 was C$0.00 Mil. BriaCell Therapeutics's Pre-Tax Income for the three months ended in Jan. 2025 was C$-9.12 Mil. Therefore, BriaCell Therapeutics's Tax Rate % for the quarter that ended in Jan. 2025 was 0.00%.

BriaCell Therapeutics Tax Rate % Historical Data

The historical data trend for BriaCell Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics Tax Rate % Chart

BriaCell Therapeutics Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Tax Rate %

Get a 7-Day Free Trial

BriaCell Therapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

BriaCell Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

BriaCell Therapeutics's Tax Rate % for the fiscal year that ended in Jul. 2024 is calculated as

Tax Rate %	=	Tax Expense (A: Jul. 2024 )	/	Pre-Tax Income (A: Jul. 2024 )
	=	0	/	-6.764
	=	0.00 %

BriaCell Therapeutics's Tax Rate % for the quarter that ended in Jan. 2025 is calculated as

Tax Rate %	=	Tax Expense (Q: Jan. 2025 )	/	Pre-Tax Income (Q: Jan. 2025 )
	=	0	/	-9.12
	=	0.00 %

BriaCell Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

BriaCell Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (TSX:BCT) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

BCTX:USA 8BT0:Germany

Address

235-15th Street, Suite 300, 3rd Floor, Bellevue Centre, West Vancouver, Vancouver, BC, CAN, V7T 2X1

Website

https://www.briacell.com

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Executives

Jamieson Bondarenko	Director
Marc Lustig	10% Security Holder, Director
Gadi Levin	Senior Officer
William Williams	Director, Senior Officer

BriaCell Therapeutics Headlines

No Headlines